Studies how often high potassium occurs in community patients with chronic kidney disease
Studies how common high potassium is in adults with chronic kidney disease.
Plain-language title generated from the registry record
Registry title: Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community
Key facts
- Where
- Shanghai, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with chronic kidney disease who are not on dialysis and are seen at community health centers. It studies how common high blood potassium is and what causes it.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Confirmed chronic kidney disease (CKD). Stable vital signs. Hematocrit level between 25% and 60%.
- Earlier treatment
- People who have started renal replacement therapy cannot join. People in other clinical trials in the past six months cannot join.
Main reasons for not taking part
- Unstable phase of acute heart or brain blood vessel disease, such as acute cerebral infarction, cerebral hemorrhage or acute coronary syndrome
- Unstable phase of severe acute diabetes complications, such as diabetic ketoacidosis or hyperosmolar hyperglycemic coma
- Currently in the acute kidney injury (AKI) stage
- Pregnant or breastfeeding women
- Unable to understand instructions or cooperate with the study procedures
Read by machine on 9 November 2026.
Where in China
- Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of MedicineShanghai, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Xiujuan Zang
- Trial code
- NCT06940414
- Record updated
- 11 July 2025
- Original description
The goal of this observational study is to investigate the prevalence and risk factors of hyperkalemia in community-based non-dialysis chronic kidney disease (CKD) patients. The main questions it aims to answer are:Read full original descriptionShow less
Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in a Community-Based Primary Care Setting
The goal of this observational study is to investigate the prevalence and risk factors of hyperkalemia in community-based non-dialysis chronic kidney disease (CKD) patients. The main questions it aims to answer are:
1. What is the prevalence of hyperkalemia in non-dialysis CKD patients in a primary care setting? 2. What are the key risk factors influencing the occurrence of hyperkalemia in this population? Researchers will collect clinical and demographic data from participants across 18 community health centers and use both point-of-care testing (POCT) and laboratory-based methods to measure serum potassium levels and related parameters.
Participants will:
1. Provide blood samples for POCT and laboratory testing. 2. Participate in interviews or questionnaires to gather clinical and lifestyle information.
The findings will be used to construct a risk prediction model for hyperkalemia, aiming to optimize screening pathways and improve disease management strategies in primary care.
Inclusion: Aged 18 years or older with stable vital signs, specifically defined as:; Body temperature: 36.0°C-38.0°C; Pulse: 50-120 beats/min; Respiratory rate: 10-24 breaths/min; Blood pressure: Systolic blood pressure ≥90 mmHg and diastolic blood pressure ≥60 mmHg; Willing to participate in the study and sign the informed consent form; Hematocrit (Hct) level between 25% and 60%; Confirmed diagnosis of chronic kidney disease (CKD).
Exclusion: Patients who have started renal replacement therapy; Patients in the unstable phase of acute cardiovascular or cerebrovascular diseases (e.g., acute cerebral infarction, cerebral hemorrhage, or acute coronary syndrome); Other conditions deemed unsuitable for participation in this clinical trial by the investigator; Patients in the unstable phase of severe acute diabetic complications (e.g., diabetic ketoacidosis or hyperosmolar hyperglycemic coma); Patients currently in the acute kidney injury (AKI) stage; Pregnant or breastfeeding women; Patients currently participating in or who have participated in other clinical trials within the past six months; Patients unable to understand verbal or written instructions, including informed consent content; Patients unable to cooperate with the study procedures.